List of LAB's Competitors and Valuation Comparisons

(PE, PB, PS, Peg, Pcf Ratio)

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Download as CSV

COMPANY NAME	TICKER	PE	PRICE TO SALES	PEG	PCF	PRICE TO BOOK
Standard Biotools Inc	LAB	-	4.22	-	-	1.37
Thermo Fisher Scientific Inc	TMO	33.04	4.95	3.92	-	4.24
Illumina Inc	ILMN	28.96	4.63	-	109.72	8.34
Agilent Technologies inc	A	28.13	6.06	1.05	-	6.44
Bio rad Laboratories Inc	BIO	-	3.34	-	-	1.27
Qiagen N v	QGEN	127.05	5.5	-	37.39	2.96
Becton Dickinson And Company	BDX	32.93	2.53	-	-	2.18
Olink Holding Ab publ	OLK	-	19.45	-	-	6.93
Cytek Biosciences Inc	CTKB	-	3.15	-	-	1.68
Bruker Corporation	BRKR	26.31	2.91	-	50.08	2.98
Akoya Biosciences Inc	AKYA	-	0.85	-	9.24	-
Astrotech Corp	ASTC	-	4.34	-	-	0.3
Avantor Inc	AVTR	-	1.13	-	-	1.34
Harvard Bioscience Inc	HBIO	-	0.39	-	15.02	2.4
Mettler Toledo International Inc	MTD	34.67	7.26	4.28	-	-
Nautilus Biotechnology Inc	NAUT	-	-	-	13.17	1.52
Singular Genomics Systems Inc	OMIC	-	18.77	-	2.75	0.41
Pressure Biosciences Inc	PBIO	-	0.02	-	-	-
Quanterix Corporation	QTRX	-	2.7	-	39.32	1.12
Rapid Micro Biosystems Inc	RPID	-	5.86	-	-	4.04
Reflect Scientific Inc	RSCF	-	2.26	-	-	1.92
Revvity Inc	RVTY	50.1	4.1	-	-	1.57
Scientific Industries Inc	SCND	2.43	0.88	-	13.99	0.63
Telesis Bio Inc	TBIO	-	0	-	-	-
10x Genomics Inc	TXG	-	3.49	-	64.55	2.84
Pacific Biosciences Of California Inc	PACB	-	4.66	-	-	19.92
AVERAGE		43	4.21	-	-	3.66

More Data on Competitors

List of Competitors by Company

List of Competitors by Segment

• Market Share

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.